These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 34365450)

  • 1. Efficacy of Low-Dose versus High-Dose Continuous Cyclic Azithromycin Therapy for Preventing Acute Exacerbations of COPD.
    Pomares X; Montón C; Huertas D; Marín A; Cuevas E; Casabella A; Martí S; Oliva JC; Santos S
    Respiration; 2021; 100(11):1070-1077. PubMed ID: 34365450
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical and Safety Outcomes of Long-Term Azithromycin Therapy in Severe COPD Beyond the First Year of Treatment.
    Pomares X; Montón C; Bullich M; Cuevas O; Oliva JC; Gallego M; Monsó E
    Chest; 2018 May; 153(5):1125-1133. PubMed ID: 29427576
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nebulized Colistin And Continuous Cyclic Azithromycin In Severe COPD Patients With Chronic Bronchial Infection Due To
    Montón C; Prina E; Pomares X; Cugat JR; Casabella A; Oliva JC; Gallego M; Monsó E
    Int J Chron Obstruct Pulmon Dis; 2019; 14():2365-2373. PubMed ID: 31802860
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term azithromycin therapy to reduce acute exacerbations in patients with severe chronic obstructive pulmonary disease.
    Naderi N; Assayag D; Mostafavi-Pour-Manshadi SM; Kaddaha Z; Joubert A; Ouellet I; Drouin I; Li PZ; Bourbeau J
    Respir Med; 2018 May; 138():129-136. PubMed ID: 29724384
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term azithromycin therapy in patients with severe COPD and repeated exacerbations.
    Pomares X; Montón C; Espasa M; Casabon J; Monsó E; Gallego M
    Int J Chron Obstruct Pulmon Dis; 2011; 6():449-56. PubMed ID: 22003290
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prophylactic antibiotic therapy for chronic obstructive pulmonary disease (COPD).
    Herath SC; Poole P
    Cochrane Database Syst Rev; 2013 Nov; (11):CD009764. PubMed ID: 24288145
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Subtypes of patients experiencing exacerbations of COPD and associations with outcomes.
    Arostegui I; Esteban C; García-Gutierrez S; Bare M; Fernández-de-Larrea N; Briones E; Quintana JM;
    PLoS One; 2014; 9(6):e98580. PubMed ID: 24892936
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term azithromycin use in patients with chronic obstructive pulmonary disease and tracheostomy.
    Blasi F; Bonardi D; Aliberti S; Tarsia P; Confalonieri M; Amir O; Carone M; Di Marco F; Centanni S; Guffanti E
    Pulm Pharmacol Ther; 2010 Jun; 23(3):200-7. PubMed ID: 20025989
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Belgian trial with azithromycin for acute COPD exacerbations requiring hospitalization: an investigator-initiated study protocol for a multicenter, randomized, double-blind, placebo-controlled trial.
    Vermeersch K; Gabrovska M; Deslypere G; Demedts IK; Slabbynck H; Aumann J; Ninane V; Verleden GM; Troosters T; Bogaerts K; Brusselle GG; Janssens W
    Int J Chron Obstruct Pulmon Dis; 2016; 11():687-96. PubMed ID: 27099485
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Azithromycin maintenance treatment in patients with frequent exacerbations of chronic obstructive pulmonary disease (COLUMBUS): a randomised, double-blind, placebo-controlled trial.
    Uzun S; Djamin RS; Kluytmans JA; Mulder PG; van't Veer NE; Ermens AA; Pelle AJ; Hoogsteden HC; Aerts JG; van der Eerden MM
    Lancet Respir Med; 2014 May; 2(5):361-8. PubMed ID: 24746000
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Azithromycin in the treatment of patients with exacerbation of chronic obstructive pulmonary disease.
    Płusa T
    Pol Merkur Lekarski; 2020 Feb; 48(283):65-68. PubMed ID: 32218410
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk stratification for short-term mortality at hospital admission for acute exacerbations of COPD.
    Sprooten RTM; Rohde GGU; Lawyer G; Leijte WT; Wouters EFM; Franssen FME
    Respirology; 2019 Aug; 24(8):765-776. PubMed ID: 30897284
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Statins and outcome after hospitalization for COPD exacerbation: a prospective study.
    Bartziokas K; Papaioannou AI; Minas M; Kostikas K; Banya W; Daniil ZD; Haniotou A; Gourgoulianis KI
    Pulm Pharmacol Ther; 2011 Oct; 24(5):625-31. PubMed ID: 21729761
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alterations in circulating mitochondrial signals at hospital admission for COPD exacerbation.
    Amado CA; Martín-Audera P; Agüero J; Ferrer-Pargada D; Josa Laorden B; Boucle D; Berja A; Lavín BA; Guerra AR; Ghadban C; Muñoz P; García-Unzueta M
    Chron Respir Dis; 2023; 20():14799731231220058. PubMed ID: 38112134
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Coding of COPD Exacerbations and the Implications on Clinical Practice, Audit and Research.
    Echevarria C; Steer J; Bourke SC
    COPD; 2020 Dec; 17(6):706-710. PubMed ID: 33169617
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Emergency Hospital Care for Exacerbation of COPD: Is Inhaled Maintenance Therapy Modified?
    Pomares X; Montón C; Baré M; Pont M; Estirado C; Gea J; Quintana JM; Vidal S; Santiago A;
    COPD; 2016; 13(1):11-8. PubMed ID: 26417965
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association between P-pulmonale and respiratory morbidity in COPD: a secondary analysis of the BLOCK-COPD trial.
    Wade RC; Mkorombindo T; Ling SX; Helgeson ES; MacDonald DM; Pew K; Voelker H; Bittner V; Kunisaki KM; Lammi MR; Dransfield MT
    BMC Pulm Med; 2023 Nov; 23(1):434. PubMed ID: 37946165
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tiotropium bromide. A review of its use as maintenance therapy in patients with COPD.
    Keam SJ; Keating GM
    Treat Respir Med; 2004; 3(4):247-68. PubMed ID: 15350163
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Blood eosinophil count and GOLD stage predict response to maintenance azithromycin treatment in COPD patients with frequent exacerbations.
    Djamin RS; Bafadhel M; Uzun S; Russell REK; Ermens AAM; Kerstens R; Aerts JGJV; Pavord ID; van der Eerden MM
    Respir Med; 2019; 154():27-33. PubMed ID: 31203097
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Can the Rome classification of chronic obstructive pulmonary disease exacerbation severity be applied in the hospital setting?
    Cometa M; Ursitti A; Lombardo LP; Rana R; Gardani A; Contoli M; Papi A
    Respir Med; 2024 Feb; 222():107509. PubMed ID: 38145723
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.